Metastatic Breast Cancer
Feature
For Radiation ‘Downwinders,’ Cancer Compensation Is On Hold
A federal program to compensate patients whose exposure to radiation caused cancer has expired, but screenings and efforts to revive and expand...
Feature
Cannabis in Cancer: What Oncologists and Patients Should Know
Access to and use of cannabis alongside cancer care have outpaced the science on evidence-based indications, according to an ASCO expert panel.
From the Journals
Risk Assessment Tool Can Help Predict Fractures in Cancer
Researchers collected data on bone mineral density and fractures in 9,877 patients with cancer and 45,875 matched control individuals without...
Feature
Popular Weight Loss Drugs Now for Patients With Cancer?
Research suggests that obesity can reduce the effectiveness of cancer therapies.
From the Journals
Does Medicare Advantage Offer Higher-Value Chemotherapy?
Researchers conducted a cohort study to look at Medicare Advantage enrollment and treatment patterns for patients with cancer receiving...
Feature
AACR Cancer Progress Report: Big Strides and Big Gaps
The report focused on strides made in cancer care, prevention, and early detection and highlighted areas where more research and attention are...
From the Journals
Cancer Risk: Are Pesticides the New Smoking?
A recent study evaluated cancer risks in the US population using a model that accounts for pesticide use and adjusts for various factors.
Conference Coverage
A Simple Blood Test May Predict Cancer Risk in T2D
Can the markers of inflammation IL-6, tumor necrosis factor alpha (TNF-alpha), and high-sensitivity C-reactive protein (hsCRP) be predictive...
Feature
Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?
Researchers analyzed whole genome sequencing data from 10,866 women in the WHI to explore possible associations between CHIP, mCA, and solid...
From the Journals
Cancer Cases, Deaths in Men Predicted to Surge by 2050
Researchers analyzed data from the 2022 Global Cancer Observatory (GLOBOCAN), which provides national-level estimates for cancer cases and deaths...
Commentary
Cancer Treatment 101: A Primer for Non-Oncologists
Doctor explains why he thinks time of diagnosis is the best time for molecular testing of a new malignant tumor.